PD173074 BI253 Pazopanib
Hydroxylated Skp1 is a substrate for Gnt1 that in turn generates a substrate for PgtA, and then AgtA, resulting PD173074 BI253 Pazopanib in formation of the pentasaccharide on Hyp143. Mutants lacking enzymes to extend to the trisaccharide state were also unable to sporulate at high O2, suggesting that hydroxylation sup ports extension of the glycan chain to three or more sugars to trigger sporulation. Though the preceding cul mination step exhibited more modest de pendence on addition of the first two sugars, the more dramatic difference in the static submerged model may simply result from failure to achieve a critical threshold of O2 in the cyst interior. The greater difference was in the role of AgtA, whose contribution was almost as important for culmination as PhyA but was unnecessary for submerged sporula tion.
Thus the role of AgtA appears to be specialized for culmination compared PD173074 BI253 Pazopanib to sporulation. The requirement of PhyA for sporulation was partially overcome by overexpression of Skp1. This suggests that PhyA action normally promotes Skp1 ac tivity, and its absence can be bypassed by excess Skp1. A related effect was observed on filter development, where Skp1 overexpression inhibited sporulation at high O2 levels that allowed culmination, but removal of PhyA blocked inhibition, indicating that PhyA tunes Skp1 activity. This is consistent with activation of Skp1 poly ubiquitination activity toward an inhibitor. In compari son, the effect of Skp1 modification on culmination im plied inhibition of Skp1 breakdown activity toward a hypothetical activator, and the effects on cyst for mation above suggested acti vation of breakdown activity toward an activator.
These disparate effects are consistent with what is known about the SCF family of E3 ubiquitin ligases, which poly ubiquitinate different substrates depending on which F box protein is present. Furthermore, these Ub ligases can have opposite effects via auto polyubiquitination of the F box protein itself, which results in protection of the substrate receptor. Conceivably, Skp1 modifica tion PD173074 BI253 Pazopanib may selectively affect these different activities. O2 is limiting for Skp1 hydroxylation in submerged culture and mechanistic implications In submerged development, substantial levels of un modified Skp1 accumulated at 5% and 21% O2.
Since i there is no evidence for enzymatic reversal of hydroxylation or glycosylation, ii the level of Skp1 was similar at different O2 levels, and iii Skp1 turns over with a half life of 12 18 h, it is likely that ap pearance of unmodified Skp1 was due to failure to hy droxylate nascent Skp1. Since the total Skp1 pool becomes 95% hydroxylated at 40% O2, O2 is likely rate limiting for Skp1 prolyl hydroxylation. This is consistent with co expression evidence that PhyA is rate limiting for Skp1 hydroxylation.